Works by Schwartz, Gregory G.


Results: 61
    1
    2

    Potential unrealized mortality benefit of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transport‐2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking program

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 97, doi. 10.1111/dom.14193
    By:
    • Salahuddin, Taufiq;
    • Richardson, Vanessa;
    • McNeal, Demetria M.;
    • Henderson, Kamal;
    • Hess, Paul L.;
    • Raghavan, Sridharan;
    • Saxon, David R.;
    • Valle, Javier A.;
    • Waldo, Stephen W.;
    • Ho, P. Michael;
    • Schwartz, Gregory G.
    Publication type:
    Article
    3
    4
    5

    Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES.

    Published in:
    European Journal of Preventive Cardiology, 2024, v. 31, n. 10, p. e75, doi. 10.1093/eurjpc/zwae110
    By:
    • Szarek, Michael;
    • Reijnders, Esther;
    • Steg, Ph Gabriel;
    • Jukema, J Wouter;
    • Schwertfeger, Markus;
    • Bhatt, Deepak L;
    • Bittner, Vera A;
    • Diaz, Rafael;
    • Fazio, Sergio;
    • Garon, Genevieve;
    • Goodman, Shaun G;
    • Harrington, Robert A;
    • White, Harvey D;
    • Zeiher, Andreas M;
    • Cobbaert, Christa;
    • Schwartz, Gregory G
    Publication type:
    Article
    6
    7

    Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEYOUTCOMES trial.

    Published in:
    European Journal of Preventive Cardiology, 2021, v. 28, n. 1, p. 33, doi. 10.1177/2047487320941987
    By:
    • Diaz, Rafael;
    • Li, Qian H.;
    • Bhatt, Deepak L.;
    • Bittner, Vera A.;
    • Baccara-Dinet, Marie T.;
    • Goodman, Shaun G.;
    • Jukema, J. Wouter;
    • Takeshi Kimura;
    • Parkhomenko, Alexander;
    • Pordy, Robert;
    • Reiner;, Željko;
    • Roe, Matthew T.;
    • Szarek, Michael;
    • Hung-Fat Tse;
    • White, Harvey D.;
    • Zahger, Doron;
    • Zeiher, Andreas M.;
    • Schwartz, Gregory G.;
    • Steg, Ph Gabriel
    Publication type:
    Article
    8
    9
    10

    Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar.

    Published in:
    PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277706
    By:
    • Grobbee, Esmée J.;
    • de Jong, Vivian D.;
    • Schrieks, Ilse C.;
    • Tushuizen, Maarten E.;
    • Holleboom, Adriaan G.;
    • Tardif, Jean-Claude;
    • Lincoff, A. Michael;
    • Schwartz, Gregory G.;
    • Castro Cabezas, Manuel;
    • Grobbee, Diederick E.
    Publication type:
    Article
    11
    12

    Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial.

    Published in:
    Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01311-9
    By:
    • Schwartz, Gregory G.;
    • Nicholls, Stephen J.;
    • Toth, Peter P.;
    • Sweeney, Michael;
    • Halliday, Christopher;
    • Johansson, Jan O.;
    • Wong, Norman C. W.;
    • Kulikowski, Ewelina;
    • Kalantar-Zadeh, Kamyar;
    • Ginsberg, Henry N.;
    • Ray, Kausik K.
    Publication type:
    Article
    13
    14

    Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial.

    Published in:
    Diabetes Care, 2025, v. 48, n. 4, p. 596, doi. 10.2337/dc24-2110
    By:
    • Schwartz, Gregory G.;
    • Szarek, Michael;
    • Jukema, J. Wouter;
    • Cobbaert, Christa M.;
    • Reijnders, Esther;
    • Bittner, Vera A.;
    • Schwertfeger, Markus;
    • Bhatt, Deepak L.;
    • Fazio, Sergio;
    • Garon, Genevieve;
    • Goodman, Shaun G.;
    • Harrington, Robert A.;
    • White, Harvey D.;
    • Steg, Philippe Gabriel
    Publication type:
    Article
    15

    Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.

    Published in:
    2021
    By:
    • Schwartz, Gregory G.;
    • Szarek, Michael;
    • Bittner, Vera A.;
    • Bhatt, Deepak L.;
    • Diaz, Rafael;
    • Goodman, Shaun G.;
    • Jukema, J. Wouter;
    • Loy, Megan;
    • Manvelian, Garen;
    • Pordy, Robert;
    • White, Harvey D.;
    • Steg, Philippe Gabriel;
    • Harrington, Robert A.;
    • Zeiher, Andreas M.;
    • Tricoci, Pierluigi;
    • Roe, Matthew T.;
    • Mahaffey, Kenneth W.;
    • Edelberg, Jay M.;
    • Hanotin, Corinne;
    • Lecorps, Guillaume
    Publication type:
    journal article
    16
    17
    18
    19
    20
    21
    22

    Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes.

    Published in:
    JAMA: Journal of the American Medical Association, 2006, v. 295, n. 17, p. 2046, doi. 10.1001/jama.295.17.2046
    By:
    • Briel, Matthias;
    • Schwartz, Gregory G.;
    • Thompson, Peter L.;
    • de Lemos, James A.;
    • Blazing, Michael A.;
    • van Es, Gerrit-Anne;
    • Kavikcioglu, Meral;
    • Arntz, Hans-Richard;
    • den Hartog, Frank R.;
    • Veeger, J. G. M.;
    • Colivicchi, Furio;
    • Dupuis, Jocelyn;
    • Okazaki, Shinya;
    • Wright, Scott;
    • Bucher, Heiner C.;
    • Nordmann, Alain J.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Tria.

    Published in:
    Journal of the American Heart Association, 2023, v. 12, n. 18, p. 1, doi. 10.1161/JAHA.122.029216
    By:
    • Goodman, Shaun G.;
    • Steg, Philippe Gabriel;
    • Poulouin, Yann;
    • Bhatt, Deepak L.;
    • Bittner, Vera A.;
    • Diaz, Rafael;
    • Garon, Genevieve;
    • Harrington, Robert A.;
    • Jukema, J. Wouter;
    • Manvelian, Garen;
    • Stipek, Wanda;
    • Szarek, Michael;
    • White, Harvey D.;
    • Schwartz, Gregory G.
    Publication type:
    Article
    34
    35
    36

    Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.

    Published in:
    JAMA: Journal of the American Medical Association, 2014, v. 311, n. 15, p. 1515, doi. 10.1001/jama.2014.3321
    By:
    • Lincoff, A. Michael;
    • Tardif, Jean-Claude;
    • Schwartz, Gregory G.;
    • Nicholls, Stephen J.;
    • Rydén, Lars;
    • Neal, Bruce;
    • Malmberg, Klas;
    • Wedel, Hans;
    • Buse, John B.;
    • Henry, Robert R.;
    • Weichert, Arlette;
    • Cannata, Ruth;
    • Svensson, Anders;
    • Volz, Dietmar;
    • Grobbee, Diederick E.
    Publication type:
    Article
    37
    38

    Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome.

    Published in:
    JAMA: Journal of the American Medical Association, 2014, v. 311, n. 3, p. 252, doi. 10.1001/jama.2013.282836
    By:
    • Nicholls, Stephen J.;
    • Kastelein, John J. P.;
    • Schwartz, Gregory G.;
    • Bash, Dianna;
    • Rosenson, Robert S.;
    • Cavender, Matthew A.;
    • Brennan, Danielle M.;
    • Koenig, Wolfgang;
    • Jukema, J. Wouter;
    • Nambi, Vijay;
    • Wright, R. Scott;
    • Menon, Venu;
    • Lincoff, A. Michael;
    • Nissen, Steven E.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46

    Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2024, v. 332, n. 23, p. 1992, doi. 10.1001/jama.2024.21957
    By:
    • Nissen, Steven E.;
    • Wang, Qiuqing;
    • Nicholls, Stephen J.;
    • Navar, Ann Marie;
    • Ray, Kausik K.;
    • Schwartz, Gregory G.;
    • Szarek, Michael;
    • Stroes, Erik S. G.;
    • Troquay, Roland;
    • Dorresteijn, Jannick A. N.;
    • Fok, Henry;
    • Rider, David A.;
    • Romano, Steven;
    • Wolski, Kathy;
    • Rambaran, Curtis
    Publication type:
    Article
    47
    48

    Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes.

    Published in:
    Diabetes & Vascular Disease Research, 2018, v. 15, n. 1, p. 14, doi. 10.1177/1479164117735493
    By:
    • Savonitto, Stefano;
    • Morici, Nuccia;
    • Nozza, Anna;
    • Cosentino, Francesco;
    • Perrone Filardi, Pasquale;
    • Murena, Ernesto;
    • Morocutti, Giorgio;
    • Ferri, Marco;
    • Cavallini, Claudio;
    • Eijkemans, Marinus J. C.;
    • Stähli, Barbara E.;
    • Schrieks, Ilse C.;
    • Toyama, Tadashi;
    • Lambers Heerspink, H. J.;
    • Malmberg, Klas;
    • Schwartz, Gregory G.;
    • Lincoff, A. Michael;
    • Ryden, Lars;
    • Tardif, Jean Claude;
    • Grobbee, Diederick E.
    Publication type:
    Article
    49
    50